Fatty heart mystery: new study probes hidden danger in rare lung disease

NCT ID NCT05462574

Recruiting now Knowledge-focused Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 08, 2026 · Last updated Jun 08, 2026

Summary

This study looks at why fat builds up in the right side of the heart in people with pulmonary arterial hypertension (PAH), a rare lung disease that strains the heart. Researchers will use heart scans and blood tests in 75 adults to see how this fat affects heart function and exercise ability. The goal is to better understand the disease, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.

HERITABLE PULMONARY ARTERIAL HYPERTENSION IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

PULMONARY ARTERIAL HYPERTENSION